Targovishte

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Depression2 trials
• Schizophrenia1 trial

Phase

• Phase 33 trials

Status

• Completed3 trials

Lead sponsor

• Intra-Cellular Therapies, Inc.3 trials

Closed trials

• Completed

  An Open-label Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

  NCT05061719· Phase 3· Intra-Cellular Therapies, Inc.· Source

• Completed

  Multicenter Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

  NCT05061706· Phase 3· Intra-Cellular Therapies, Inc.· Source

• Completed

  Lumateperone for the Prevention of Relapse in Patients With Schizophrenia

  NCT04959032· Phase 3· Intra-Cellular Therapies, Inc.· Source